About us

We are a clinical-stage company mainly focused on the drug discovery & development of novel therapies for cancer treatment. We have a world-class MedChem team, mainly pursue clinically validated targets with significant unmet needs, challenging medicinal chemistry, and strong interests from big pharma, particularly the targets with strong synergy with Bcl-2 pathway. Our drug design team dedicate to the rational drug design of proprietary drug candidates with strong differentiations. Our clinical teams have deep experience in rapid and cost-effective completion of clinical proof-of-concept (POC) and pivotal studies in China and US. We strive to bring newest generation medicines to cancer patients worldwide.